Virtus ETF Advisers’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-19,523
Closed -$340K 650
2024
Q4
$340K Sell
19,523
-25,967
-57% -$452K 0.14% 217
2024
Q3
$636K Hold
45,490
0.3% 172
2024
Q2
$374K Buy
45,490
+1,340
+3% +$11K 0.18% 187
2024
Q1
$340K Buy
44,150
+6,352
+17% +$49K 0.18% 216
2023
Q4
$340K Buy
37,798
+19,817
+110% +$178K 0.22% 196
2023
Q3
$161K Sell
17,981
-2,328
-11% -$20.8K 0.1% 308
2023
Q2
$312K Buy
20,309
+3,635
+22% +$55.8K 0.18% 195
2023
Q1
$375K Buy
16,674
+293
+2% +$6.59K 0.21% 152
2022
Q4
$344K Buy
16,381
+6,362
+63% +$134K 0.18% 220
2022
Q3
$247K Buy
10,019
+144
+1% +$3.55K 0.1% 291
2022
Q2
$239K Sell
9,875
-4,241
-30% -$103K 0.09% 307
2022
Q1
$364K Hold
14,116
0.16% 158
2021
Q4
$438K Sell
14,116
-15,427
-52% -$479K 0.17% 128
2021
Q3
$716K Sell
29,543
-2,711
-8% -$65.7K 0.32% 100
2021
Q2
$471K Buy
32,254
+8,347
+35% +$122K 0.19% 168
2021
Q1
$597K Buy
+23,907
New +$597K 0.25% 123
2020
Q4
Sell
-38,150
Closed -$704K 361
2020
Q3
$704K Buy
38,150
+3,213
+9% +$59.3K 0.37% 104
2020
Q2
$713K Sell
34,937
-6,123
-15% -$125K 0.34% 95
2020
Q1
$599K Sell
41,060
-3,465
-8% -$50.5K 0.25% 152
2019
Q4
$632K Buy
44,525
+8,428
+23% +$120K 0.1% 176
2019
Q3
$418K Sell
36,097
-6,064
-14% -$70.2K 0.08% 187
2019
Q2
$847K Buy
+42,161
New +$847K 0.18% 171
2019
Q1
Sell
-24,796
Closed -$561K 260
2018
Q4
$561K Sell
24,796
-3,271
-12% -$74K 0.1% 64
2018
Q3
$806K Buy
28,067
+1,891
+7% +$54.3K 0.08% 64
2018
Q2
$714K Sell
26,176
-15,627
-37% -$426K 0.63% 95
2018
Q1
$935K Sell
41,803
-2,494
-6% -$55.8K 0.81% 52
2017
Q4
$933K Sell
44,297
-12,356
-22% -$260K 1.17% 39
2017
Q3
$1.41M Hold
56,653
0.19% 39
2017
Q2
$1.1M Buy
56,653
+5,036
+10% +$97.7K 0.16% 50
2017
Q1
$953K Buy
51,617
+4,963
+11% +$91.6K 0.17% 72
2016
Q4
$883K Buy
46,654
+9,061
+24% +$171K 0.26% 74
2016
Q3
$841K Buy
37,593
+4,736
+14% +$106K 0.41% 40
2016
Q2
$585K Buy
32,857
+4,223
+15% +$75.2K 0.43% 29
2016
Q1
$391K Hold
28,634
0.54% 51
2015
Q4
$552K Buy
+28,634
New +$552K 1.52% 24